Real-world experience with the IUB Ballerine MIDI copper IUD: an observational, single-centre study in Israel

被引:3
|
作者
Baram, Ilan [1 ,2 ]
Aharon, Arnon [2 ]
Klein, Rinat [2 ]
Shkolnik, Ketty [2 ]
机构
[1] Maccabi Healthcare Serv, Modiin, Israel
[2] OCON Healthcare, Clin Dev, Modiin, Israel
关键词
Contraceptive; IUB; IUB Ballerine MIDI; IUD; LARC; UNINTENDED PREGNANCY; CONTRACEPTIVE METHODS; INTRAUTERINE-DEVICE; UNITED-STATES; EFFICACY;
D O I
10.1080/13625187.2019.1699048
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: The aim of the study was to assess the acceptability of the intrauterine ball IUB Ballerine MIDI copper intrauterine device (IUD), using real-world data collected from users and physicians in Israel. Methods: In this retrospective, observational study, conducted in a single clinic in Israel, healthy women (n = 175) who had had the device inserted >= 12 months prior to enrolment, and their physician, completed questionnaires relating to device insertion, user experience and performance. Results: The mean age at insertion was 32.8 +/- 6.7 years; most women were married (80.6%) and multigravid (89.1%). At the time of the study, 131 (74.9%) women were still using the device; in 13 cases (7.4%), premature removal was due to desire to conceive. The 12 month continuation rate, excluding the women seeking to conceive, was 90.1%. The expulsion rate was 3.4% (n = 6) and the pregnancy rate was 0.57% (n = 1). Most of the women still using the device reported no to moderate pain or cramps (90.0%) and moderate to high (72.6%) satisfaction with the device; 76.3% said they would recommend it to friends and relatives. Most of the insertion procedures (86.9%) were uneventful and none required cervical dilation. Conclusion: The IUB Ballerine MIDI raised no major safety concerns and was both effective and highly accepted in a cohort of women, covering a broad age range, treated in a gynaecology clinic in Israel.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 50 条
  • [41] Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience
    Abawi, M.
    Nijhoff, F.
    Stella, P. R.
    Voskuil, M.
    Benedetto, D.
    Doevendans, P. A.
    Agostoni, P.
    NETHERLANDS HEART JOURNAL, 2016, 24 (09) : 544 - 551
  • [42] Letter: tofacitinib in biologic-experienced ulcerative colitis-a single-centre real-world experience in Australia
    Lo, S. W.
    Connell, W.
    Kamm, M. A.
    Lust, M.
    Wright, E. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (04) : 532 - 533
  • [43] Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience
    M. Abawi
    F. Nijhoff
    P.R. Stella
    M. Voskuil
    D. Benedetto
    P.A. Doevendans
    P. Agostoni
    Netherlands Heart Journal, 2016, 24 : 544 - 551
  • [44] Pregnancy in BRCA-carrier patients after breast cancer therapy: single-centre real-world experience
    Bettazzi, Beatrice
    Visani, Luca
    Gensini, Francesca
    Olmetto, Emanuela
    Garlatti, Pietro
    Desideri, Isacco
    Scoccimarro, Erika
    Di Cataldo, Vanessa
    Bonomo, Pierluigi
    Peruzzi, Anna
    Frosini, Giulio
    Caprara, Luisa
    Valzano, Marianna
    Bernini, Marco
    Orzalesi, Lorenzo
    Nori, Jacopo
    Bianchi, Simonetta
    Becherini, Carlotta
    Salvestrini, Viola
    Livi, Lorenzo
    Meattini, Icro
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S614 - S616
  • [45] Real-world efficacy and safety of naltrexone-bupropion therapy in Chinese patients with obesity: A single-centre experience
    Lui, David Tak Wai
    Tsoi, Kimberly Hang
    Fong, Carol Ho Yi
    Jiang, Nancy Su
    Chow, Wing Sun
    Yuen, Michele Mae Ann
    ENDOCRINE, 2025, 87 (02) : 522 - 529
  • [46] FOLFIRINOX vs gemcitabine nab-paclitaxel: A real-world efficacy and safety analysis - a single-centre experience
    Khan, A. M.
    Noor, S.
    Ahmed, R.
    Takreem, S.
    Shahnoor, S. S.
    Muddu, V. K.
    Bonda, A.
    Siripurapu, I.
    Krishnaiah, S.
    Rao, G.
    Reddy, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S152 - S152
  • [47] Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis
    Elgaard, Cathrine Dawn Buttner
    Iversen, Lars
    Hjuler, Kasper Fjellhaugen
    DRUGS IN R&D, 2023, 23 (02) : 155 - 163
  • [48] Adult-onset sporadic chorea: real-world data from a single-centre retrospective study
    Roberta Bovenzi
    Matteo Conti
    Rocco Cerroni
    Mariangela Pierantozzi
    Alessandro Stefani
    Antonio Pisani
    Nicola Biagio Mercuri
    Tommaso Schirinzi
    Neurological Sciences, 2022, 43 : 387 - 392
  • [49] Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis
    Cathrine Dawn Büttner Elgaard
    Lars Iversen
    Kasper Fjellhaugen Hjuler
    Drugs in R&D, 2023, 23 : 155 - 163
  • [50] Adult-onset sporadic chorea: real-world data from a single-centre retrospective study
    Bovenzi, Roberta
    Conti, Matteo
    Cerroni, Rocco
    Pierantozzi, Mariangela
    Stefani, Alessandro
    Pisani, Antonio
    Mercuri, Nicola Biagio
    Schirinzi, Tommaso
    NEUROLOGICAL SCIENCES, 2022, 43 (01) : 387 - 392